Number of the records: 1
CD161 receptor participates in both impairing NK cell cytotoxicity and the response to glycans and vimentin in patients with rheumatoid arthritis
- 1.Richter, J., Benson, V., Grobárová, V., Svoboda, J., Vencovský, J., Svobodová, R., Fišerová, A. CD161 receptor participates in both impairing NK cell cytotoxicity and the response to glycans and vimentin in patients with rheumatoid arthritis. Clinical Immunology. 2010, 136(1), 139-147. ISSN 1521-6616. E-ISSN 1521-7035. Available: doi: 10.1016/j.clim.2010.03.005
Number of the records: 1